The PBS listing for ixekizumab (Taltz) has been extended to include adult patients with active ankylosing spondylitis (AS). Ixekizumab was already available on the PBS for severe psoriatic arthritis and severe chronic plaque psoriasis. The PBAC’s decision to recommend the new PBS listing was made largely on the basis of evidence from the COAST and ...
IL-17A inhibitor listed on the PBS for ankylosing spondylitis
By Mardi Chapman
3 Dec 2020